Variant report

rSNPs within LD-proxies of this variant (count:20)

rs_ID	r²[population]
rs10733310	0.85[CEU][hapmap];0.82[AMR][1000 genomes];0.80[EUR][1000 genomes]
rs10810565	1.00[CEU][hapmap]
rs12000878	0.81[CEU][hapmap]
rs13301531	0.81[CEU][hapmap]
rs1887619	0.85[CEU][hapmap]
rs1927620	0.85[EUR][1000 genomes]
rs1927621	1.00[CEU][hapmap];0.84[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs1927635	0.84[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs1927636	1.00[CEU][hapmap];0.90[EUR][1000 genomes]
rs1927639	0.88[CEU][hapmap];0.82[EUR][1000 genomes]
rs2149161	0.82[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2149163	0.84[CEU][hapmap];0.84[EUR][1000 genomes]
rs2382802	0.84[EUR][1000 genomes]
rs2382803	0.84[EUR][1000 genomes]
rs6475054	0.85[CEU][hapmap]
rs7021534	0.85[YRI][hapmap]
rs7043935	0.89[CEU][hapmap];0.80[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs7046026	0.84[CEU][hapmap]
rs7046416	1.00[CEU][hapmap];0.86[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs7856233	0.83[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv530933	chr9:16251206-16830845	Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
2	nsv530934	chr9:16281246-16779432	Strong transcription Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:19 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16421800-16460400	Weak transcription	Aorta	Aorta
2	chr9:16432600-16450600	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr9:16437400-16459200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
4	chr9:16437600-16450600	Weak transcription	Fetal Stomach	stomach
5	chr9:16437600-16450600	Weak transcription	Stomach Smooth Muscle	stomach
6	chr9:16438800-16458800	Weak transcription	HSMM	muscle
7	chr9:16442800-16453800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr9:16442800-16455800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
9	chr9:16443000-16449800	Weak transcription	Ovary	ovary
10	chr9:16445800-16453600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
11	chr9:16446000-16458800	Weak transcription	NHLF	lung
12	chr9:16446400-16458800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr9:16447000-16457600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr9:16447000-16458400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr9:16447400-16452200	Enhancers	Rectal Smooth Muscle	rectum
16	chr9:16447800-16450000	Enhancers	Colon Smooth Muscle	Colon
17	chr9:16448400-16450600	Weak transcription	Duodenum Smooth Muscle	Duodenum
18	chr9:16448800-16451200	Enhancers	Fetal Heart	heart
19	chr9:16449200-16459200	Weak transcription	iPS-15b Cell Line	embryonic stem cell

Quick Search: